Global Gastrointestinal Diseases Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	174 Pages	TechNavio	July, 2024	INF19033436

Best Price Guarantee
Price	from $2,500
Length	174 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033436

Global Gastrointestinal Diseases Therapeutics Market 2024-2028

The gastrointestinal diseases therapeutics market is forecasted to grow by USD 18526.1 mn during 2023-2028, accelerating at a CAGR of 6.81% during the forecast period. The report on the gastrointestinal diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of gastrointestinal diseases, new gastrointestinal therapeutics product launches, and increasing demand for biologics and targeted therapies.

Technavio's gastrointestinal diseases therapeutics market is segmented as below:

By Drug Class

Anti-inflammatory and immunosuppressors
Acid neutralizers
Others

By Type

Branded
Generics

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the availability of nutritional therapies as one of the prime reasons driving the gastrointestinal diseases therapeutics market growth during the next few years. Also, emergence of microbiome-based therapies and increase in self-medication coupled with home-based therapies will lead to sizable demand in the market.

The report on the gastrointestinal diseases therapeutics market covers the following areas:

Gastrointestinal diseases therapeutics market sizing
Gastrointestinal diseases therapeutics market forecast
Gastrointestinal diseases therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastrointestinal diseases therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Boston Scientific Corp., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Olympus Corp., Ovesco Endoscopy AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and UCB SA. Also, the gastrointestinal diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Drug Class; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Gastrointestinal Diseases Therapeutics Market 2018 - 2022; Historic Market Size - Data Table on Global Gastrointestinal Diseases Therapeutics Market 2018 - 2022 ($ million); 4.2 Drug Class segment analysis 2018 - 2022; Historic Market Size - Drug Class Segment 2018 - 2022 ($ million); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Drug Class: 6.1 Market segments; Chart on Drug Class - Market share 2023-2028 (%); Data Table on Drug Class - Market share 2023-2028 (%); 6.2 Comparison by Drug Class; Chart on Comparison by Drug Class; Data Table on Comparison by Drug Class; 6.3 Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028; Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028 ($ million); Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028 ($ million); Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2023-2028 (%); Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2023-2028 (%); 6.4 Acid neutralizers - Market size and forecast 2023-2028; Chart on Acid neutralizers - Market size and forecast 2023-2028 ($ million); Data Table on Acid neutralizers - Market size and forecast 2023-2028 ($ million); Chart on Acid neutralizers - Year-over-year growth 2023-2028 (%); Data Table on Acid neutralizers - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Drug Class; Market opportunity by Drug Class ($ million); Data Table on Market opportunity by Drug Class ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Branded - Market size and forecast 2023-2028; Chart on Branded - Market size and forecast 2023-2028 ($ million); Data Table on Branded - Market size and forecast 2023-2028 ($ million); Chart on Branded - Year-over-year growth 2023-2028 (%); Data Table on Branded - Year-over-year growth 2023-2028 (%); 7.4 Generics - Market size and forecast 2023-2028; Chart on Generics - Market size and forecast 2023-2028 ($ million); Data Table on Generics - Market size and forecast 2023-2028 ($ million); Chart on Generics - Year-over-year growth 2023-2028 (%); Data Table on Generics - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.5 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.11 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 12.6 Bausch Health Companies Inc.; Bausch Health Companies Inc. - Overview; Bausch Health Companies Inc. - Business segments; Bausch Health Companies Inc. - Key news; Bausch Health Companies Inc. - Key offerings; Bausch Health Companies Inc. - Segment focus; 12.7 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.8 Biogen Inc.; Biogen Inc. - Overview; Biogen Inc. - Product / Service; Biogen Inc. - Key news; Biogen Inc. - Key offerings; 12.9 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; 12.10 Boston Scientific Corp.; Boston Scientific Corp. - Overview; Boston Scientific Corp. - Business segments; Boston Scientific Corp. - Key news; Boston Scientific Corp. - Key offerings; Boston Scientific Corp. - Segment focus; 12.11 Eisai Co. Ltd.; Eisai Co. Ltd. - Overview; Eisai Co. Ltd. - Business segments; Eisai Co. Ltd. - Key offerings; Eisai Co. Ltd. - Segment focus; 12.12 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.13 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.14 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; 12.15 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.16 UCB SA; UCB SA - Overview; UCB SA - Product / Service; UCB SA - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Gastrointestinal Diseases Therapeutics Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Drug Class - Market share 2023-2028 (%); Exhibits33: Data Table on Drug Class - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Drug Class; Exhibits35: Data Table on Comparison by Drug Class; Exhibits36: Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Acid neutralizers - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Acid neutralizers - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Acid neutralizers - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Acid neutralizers - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by Drug Class ($ million); Exhibits49: Data Table on Market opportunity by Drug Class ($ million); Exhibits50: Chart on Type - Market share 2023-2028 (%); Exhibits51: Data Table on Type - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Type; Exhibits53: Data Table on Comparison by Type; Exhibits54: Chart on Branded - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Branded - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Branded - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Branded - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Generics - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Generics - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Generics - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Generics - Year-over-year growth 2023-2028 (%); Exhibits62: Market opportunity by Type ($ million); Exhibits63: Data Table on Market opportunity by Type ($ million); Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits67: Chart on Geographic comparison; Exhibits68: Data Table on Geographic comparison; Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits105: Market opportunity By Geographical Landscape ($ million); Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits107: Impact of drivers and challenges in 2023 and 2028; Exhibits108: Overview on criticality of inputs and factors of differentiation; Exhibits109: Overview on factors of disruption; Exhibits110: Impact of key risks on business; Exhibits111: Companies covered; Exhibits112: Matrix on companies position and classification; Exhibits113: Abbott Laboratories - Overview; Exhibits114: Abbott Laboratories - Business segments; Exhibits115: Abbott Laboratories - Key news; Exhibits116: Abbott Laboratories - Key offerings; Exhibits117: Abbott Laboratories - Segment focus; Exhibits118: AbbVie Inc. - Overview; Exhibits119: AbbVie Inc. - Product / Service; Exhibits120: AbbVie Inc. - Key news; Exhibits121: AbbVie Inc. - Key offerings; Exhibits122: AstraZeneca Plc - Overview; Exhibits123: AstraZeneca Plc - Product / Service; Exhibits124: AstraZeneca Plc - Key news; Exhibits125: AstraZeneca Plc - Key offerings; Exhibits126: Bausch Health Companies Inc. - Overview; Exhibits127: Bausch Health Companies Inc. - Business segments; Exhibits128: Bausch Health Companies Inc. - Key news; Exhibits129: Bausch Health Companies Inc. - Key offerings; Exhibits130: Bausch Health Companies Inc. - Segment focus; Exhibits131: Bayer AG - Overview; Exhibits132: Bayer AG - Business segments; Exhibits133: Bayer AG - Key news; Exhibits134: Bayer AG - Key offerings; Exhibits135: Bayer AG - Segment focus; Exhibits136: Biogen Inc. - Overview; Exhibits137: Biogen Inc. - Product / Service; Exhibits138: Biogen Inc. - Key news; Exhibits139: Biogen Inc. - Key offerings; Exhibits140: Boehringer Ingelheim International GmbH - Overview; Exhibits141: Boehringer Ingelheim International GmbH - Product / Service; Exhibits142: Boehringer Ingelheim International GmbH - Key news; Exhibits143: Boehringer Ingelheim International GmbH - Key offerings; Exhibits144: Boston Scientific Corp. - Overview; Exhibits145: Boston Scientific Corp. - Business segments; Exhibits146: Boston Scientific Corp. - Key news; Exhibits147: Boston Scientific Corp. - Key offerings; Exhibits148: Boston Scientific Corp. - Segment focus; Exhibits149: Eisai Co. Ltd. - Overview; Exhibits150: Eisai Co. Ltd. - Business segments; Exhibits151: Eisai Co. Ltd. - Key offerings; Exhibits152: Eisai Co. Ltd. - Segment focus; Exhibits153: GlaxoSmithKline Plc - Overview; Exhibits154: GlaxoSmithKline Plc - Business segments; Exhibits155: GlaxoSmithKline Plc - Key news; Exhibits156: GlaxoSmithKline Plc - Key offerings; Exhibits157: GlaxoSmithKline Plc - Segment focus; Exhibits158: Johnson and Johnson Services Inc. - Overview; Exhibits159: Johnson and Johnson Services Inc. - Business segments; Exhibits160: Johnson and Johnson Services Inc. - Key news; Exhibits161: Johnson and Johnson Services Inc. - Key offerings; Exhibits162: Johnson and Johnson Services Inc. - Segment focus; Exhibits163: Merck and Co. Inc. - Overview; Exhibits164: Merck and Co. Inc. - Business segments; Exhibits165: Merck and Co. Inc. - Key news; Exhibits166: Merck and Co. Inc. - Key offerings; Exhibits167: Merck and Co. Inc. - Segment focus; Exhibits168: Pfizer Inc. - Overview; Exhibits169: Pfizer Inc. - Product / Service; Exhibits170: Pfizer Inc. - Key news; Exhibits171: Pfizer Inc. - Key offerings; Exhibits172: UCB SA - Overview; Exhibits173: UCB SA - Product / Service; Exhibits174: UCB SA - Key offerings; Exhibits175: Inclusions checklist; Exhibits176: Exclusions checklist; Exhibits177: Currency conversion rates for US$; Exhibits178: Research methodology; Exhibits179: Information sources; Exhibits180: Data validation; Exhibits181: Validation techniques employed for market sizing; Exhibits182: Data synthesis; Exhibits183: 360 degree market analysis; Exhibits184: List of abbreviations